Changlin Dou

670 total citations
18 papers, 506 citations indexed

About

Changlin Dou is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Changlin Dou has authored 18 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Changlin Dou's work include Biosimilars and Bioanalytical Methods (3 papers), Developmental Biology and Gene Regulation (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Changlin Dou is often cited by papers focused on Biosimilars and Bioanalytical Methods (3 papers), Developmental Biology and Gene Regulation (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Changlin Dou collaborates with scholars based in China and United States. Changlin Dou's co-authors include Eseng Lai, Joel M. Levine, Bo Liu, Stephanie Morgan, Bo Liu, Qiwei Wang, Jun Ren, Joan Massagué, Shouhong Xuan and Jun Lee and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and PLoS ONE.

In The Last Decade

Changlin Dou

14 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changlin Dou China 8 321 99 94 75 52 18 506
Woosung Cho United States 9 275 0.9× 68 0.7× 68 0.7× 77 1.0× 35 0.7× 11 514
Tokuichi Iguchi Japan 10 303 0.9× 123 1.2× 53 0.6× 38 0.5× 20 0.4× 17 451
Annabel Christ Germany 14 321 1.0× 71 0.7× 66 0.7× 101 1.3× 21 0.4× 18 556
Jonathan T. Fleming United States 10 351 1.1× 78 0.8× 153 1.6× 103 1.4× 35 0.7× 12 483
Ruth Simon United States 12 694 2.2× 112 1.1× 79 0.8× 200 2.7× 76 1.5× 16 853
Carlos E. Pedraza United States 8 281 0.9× 151 1.5× 131 1.4× 60 0.8× 15 0.3× 11 513
Scott E. LeBlanc United States 13 452 1.4× 188 1.9× 67 0.7× 56 0.7× 18 0.3× 13 635
Gernot Neumayer Canada 11 304 0.9× 68 0.7× 53 0.6× 52 0.7× 35 0.7× 13 507
Jonas Doerr Germany 8 671 2.1× 280 2.8× 96 1.0× 47 0.6× 24 0.5× 10 811
Mathieu Daynac France 14 377 1.2× 101 1.0× 286 3.0× 37 0.5× 30 0.6× 18 619

Countries citing papers authored by Changlin Dou

Since Specialization
Citations

This map shows the geographic impact of Changlin Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlin Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlin Dou more than expected).

Fields of papers citing papers by Changlin Dou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changlin Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlin Dou. The network helps show where Changlin Dou may publish in the future.

Co-authorship network of co-authors of Changlin Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Changlin Dou. A scholar is included among the top collaborators of Changlin Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changlin Dou. Changlin Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Han, Xiaolei, et al.. (2024). Unlocking the potential of melanotransferrin (CD228): implications for targeted drug development and novel therapeutic avenues. Expert Opinion on Therapeutic Targets. 28(12). 1117–1129.
3.
Ding, Yanhua, et al.. (2023). A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva®) in healthy Chinese subjects. Journal of bone oncology. 42. 100499–100499. 1 indexed citations
4.
Zhang, Qin, Cheng Sun, Jinying Wu, et al.. (2023). Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects. Expert Opinion on Biological Therapy. 23(8). 727–735. 2 indexed citations
5.
6.
Yu, Pengfei, et al.. (2022). Non-clinical pharmacology and toxicology studies of bevacizumab biosimilar LY01008. European Journal of Pharmacology. 936. 175383–175383. 1 indexed citations
7.
Liu, Xiu, Qiao‐Ping Wang, Chunjie Sha, et al.. (2021). Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity. Scientific Reports. 11(1). 22966–22966. 13 indexed citations
8.
9.
10.
Wang, Qiwei, Jun Ren, Stephanie Morgan, et al.. (2014). Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm. PLoS ONE. 9(3). e92053–e92053. 63 indexed citations
11.
Ren, Jun, Qiwei Wang, Stephanie Morgan, et al.. (2014). Protein Kinase C-δ (PKCδ) Regulates Proinflammatory Chemokine Expression through Cytosolic Interaction with the NF-κB Subunit p65 in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 289(13). 9013–9026. 50 indexed citations
12.
Shi, Yanan, Fengying Sun, Dan Wang, et al.. (2013). Enhancement of bioavailability by formulating rhEPO ionic complex with lysine into PEG–PLA micelle. Journal of Nanoparticle Research. 15(10). 3 indexed citations
13.
Dou, Changlin, Jun Lee, Bo Liu, et al.. (2000). BF-1 Interferes with Transforming Growth Factor β Signaling by Associating with Smad Partners. Molecular and Cellular Biology. 20(17). 6201–6211. 91 indexed citations
14.
Liu, Bo, et al.. (1999). FAST-2 Is a Mammalian Winged-Helix Protein Which Mediates Transforming Growth Factor β Signals. Molecular and Cellular Biology. 19(1). 424–430. 80 indexed citations
15.
Dou, Changlin. (1999). Dual Role of Brain Factor-1 in Regulating Growth and Patterning of the Cerebral Hemispheres. Cerebral Cortex. 9(6). 543–550. 120 indexed citations
16.
Dou, Changlin & Joel M. Levine. (1997). Identification of a Neuronal Cell Surface Receptor for a Growth Inhibitory Chondroitin Sulfate Proteoglycan (NG2). Journal of Neurochemistry. 68(3). 1021–1030. 42 indexed citations
17.
Dou, Changlin, Xin Ye, Colin L. Stewart, Eseng Lai, & Suzanne C. Li. (1997). TWH Regulates the Development of Subsets of Spinal Cord Neurons. Neuron. 18(4). 539–551. 35 indexed citations
18.
Levine, Joel M. & Changlin Dou. (1991). Regulation of Glial Development by Cell Line Derived Factors. Annals of the New York Academy of Sciences. 633(1). 515–517. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Woosung Cho Breakdown of academic impact, for papers by Tokuichi Iguchi Breakdown of academic impact, for papers by Annabel Christ Breakdown of academic impact, for papers by Jonathan T. Fleming Breakdown of academic impact, for papers by Ruth Simon Breakdown of academic impact, for papers by Carlos E. Pedraza Breakdown of academic impact, for papers by Scott E. LeBlanc Breakdown of academic impact, for papers by Gernot Neumayer Breakdown of academic impact, for papers by Jonas Doerr Breakdown of academic impact, for papers by Mathieu Daynac
Rankless by CCL
2026